Gossamer Bio (GOSS) EBIAT: 2022-2025
Historic EBIAT for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$48.2 million.
- Gossamer Bio's EBIAT fell 56.55% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$156.2 million, marking a year-over-year decrease of 117.96%. This contributed to the annual value of -$56.5 million for FY2024, which is 68.56% up from last year.
- Per Gossamer Bio's latest filing, its EBIAT stood at -$48.2 million for Q3 2025, which was down 25.99% from -$38.3 million recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's EBIAT ranged from a high of $49.2 million in Q2 2024 and a low of -$59.4 million during Q3 2022.
- Over the past 3 years, Gossamer Bio's median EBIAT value was -$40.0 million (recorded in 2023), while the average stood at -$32.7 million.
- Per our database at Business Quant, Gossamer Bio's EBIAT skyrocketed by 215.85% in 2024 and then plummeted by 177.74% in 2025.
- Over the past 4 years, Gossamer Bio's EBIAT (Quarterly) stood at -$55.8 million in 2022, then climbed by 13.66% to -$48.1 million in 2023, then surged by 31.40% to -$33.0 million in 2024, then tumbled by 56.55% to -$48.2 million in 2025.
- Its EBIAT was -$48.2 million in Q3 2025, compared to -$38.3 million in Q2 2025 and -$36.6 million in Q1 2025.